Skip to content

Public FDA record

Z-2321-2025: Description/REF: BD PYXIS MEDBANK MINI 1FH-1FM/169-137, BD PYXIS MEDBANK MINI 4HM/169-113, BD PYXIS M

Recall record Z-2321-2025 for CareFusion 303, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2321-2025
Company in FDA record
CareFusion 303, Inc.
FDA classification date
Aug 13, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

Reports of delayed access to medication in automated dispensing cabinets because of the override/Add Item workflow.

Source facts

Action
On 7/10/2025, correction notices were mailed and emailed to customers who were informed of the following: Firm strengthened its user guide content regarding manual access to medications. To access the updated content for the user guide and nursing training material, visit the MedBank Customer Portal at https://bd.com/medbankportal When selecting a medication from override/add item function, it is important for users to use extra precautions and verify correct medications are selected and pulled as undesired medications could be displayed on the override list. Firm recommends the following actions to prevent delays in access to medication: 1) Make sure staff know how to use the override/add-item workflow. 2) Have device keys available on-site in a secure location known to designated staff. 3) Train staff on how to manually access the device, see User Guide. 4) Ensure downtime policies and procedures are implemented and staff are appropriately trained Enable Over-ride permission. 5) Do not use the station as a crash cart or code box. Medication or items may not be immediately accessible for an emergent situation causing a delay in treatment which could lead to serious injury or death. 6) For pharmacies providing products to clinical users that are not physically located at the pharmacy site, ensure clinical users are aware of the risk of delay in access and provide access to keys. 7) Protocols for retrieving medications from alternative inventory locations 8) Guidance on storing time-sensitive or critical medications outside of automated dispensing devices to prevent access delays. 9) Complete and return the response form via email to BDRC9@bd.com Distributors: provide a copy of this customer letter to any customers who may have received impacted devices. Firm is evaluating design enhancements to improve usability of the override/Add Item workflow. Report any device issues via phone: 866-930-9251
Initiated
2025-07-10
Root cause
Use error
Distribution
US Nationwide distribution including in the states of NY, MA, KY, VA, OR, OH, FL, WA, MS, OK, TN, PA, RI, TX, SC, AR, MI, NJ, CT, MD, AZ, CA, WV, NC, UT, WY, CO, SD, ID, IL, IN, NV, NM, NE, KS, GA, WI, MO, IA, ME, LA, MN, AL, VT, NH, DE, MT, ND, AK, HI, DC.
Recall number
Z-2321-2025
Recall status
Open, Classified
CDRH record ID
214952
FDA classified
2025-08-13
Recall event number
97245

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗